salicylsalicylic acid has been researched along with Ache in 3 studies
salicylsalicylic acid: structure
salsalate : A dimeric benzoate ester obtained by intermolecular condensation between the carboxy of one molecule of salicylic acid with the phenol group of a second. It is a prodrug for salycylic acid that is used for treatment of rheumatoid arthritis and osteoarthritis and also shows activity against type II diabetes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pain is a serious adverse event which frequently accompanies hematopoietic stem cell transplantation (HSCT)." | 1.62 | The non-steroidal anti-inflammatory drug salsalate provides safe and effective control of mucositis-unrelated pain during autologous and allogeneic hematopoietic stem cell transplantation. ( Gordon, L; Grosshans, N; Mehta, J; Rubin, H; Trifilio, S, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Trifilio, S | 1 |
| Gordon, L | 1 |
| Rubin, H | 1 |
| Grosshans, N | 1 |
| Mehta, J | 1 |
| Bombardier, C | 1 |
| Peloso, PM | 1 |
| Goldsmith, CH | 1 |
| Powell, ML | 1 |
| Ehrlich, A | 1 |
| Belsito, DV | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Regulation of Nitric Oxide Bioavailability in Chronic Obstructive Pulmonary Disease: A Mechanistic Approach[NCT01398943] | 60 participants (Actual) | Interventional | 2010-09-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Brachial artery FMD induced by reactive hyperemia will be used to assess vascular endothelial function at baseline and several hours after each experimental intervention. (NCT01398943)
Timeframe: Post FMD was taken approximately 110 min after baseline
| Intervention | percentage of change in FMD (Mean) | |
|---|---|---|
| Placebo | AOC Treatment | |
| All Controls | 6.7 | 6.9 |
| All COPD Patients | 3.1 | 4.7 |
A measure of vascular stiffness at baseline and several hours after each experimental intervention. (NCT01398943)
Timeframe: Post PWV was taken approximately 90 min after baseline
| Intervention | m/sec (Mean) | |
|---|---|---|
| Placebo | AOC Treatment | |
| All Controls | 11 | 10 |
| All COPD Patients | 14 | 11 |
1 trial available for salicylsalicylic acid and Ache
| Article | Year |
|---|---|
Salsalate, a nonacetylated salicylate, is as efficacious as diclofenac in patients with rheumatoid arthritis. Salsalate-Diclofenac Study Group.
Topics: Aged; Arthritis, Rheumatoid; Diclofenac; Double-Blind Method; Female; Humans; Male; Middle Aged; Mul | 1995 |
2 other studies available for salicylsalicylic acid and Ache
| Article | Year |
|---|---|
The non-steroidal anti-inflammatory drug salsalate provides safe and effective control of mucositis-unrelated pain during autologous and allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Female; Hematopoietic Stem Cell Transplantatio | 2021 |
Lichenoid drug eruption to salsalate.
Topics: Administration, Topical; Aged; Aged, 80 and over; Arthritis; Drug Eruptions; Humans; Lichen Planus; | 2001 |